Beurs gesloten -
Bombay S.E.
12:00:50 03-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
139,8
INR
|
-0,21%
|
|
-2,88%
|
-16,81%
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
16.363
|
12.131
|
6.692
|
10.958
|
9.077
|
6.643
|
Bedrijfswaarde
1 |
25.570
|
18.451
|
13.711
|
18.241
|
3.926
|
4.714
|
K/w-verhouding
|
-22,1
x
|
32,2
x
|
-3,44
x
|
-7,42
x
|
0,84
x
|
-20
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,76
x
|
2,66
x
|
1,23
x
|
1,75
x
|
1,37
x
|
1,44
x
|
Bedrijfswaarde/omzet
|
4,31
x
|
4,04
x
|
2,52
x
|
2,92
x
|
0,59
x
|
1,02
x
|
Bedrijfswaarde/EBITDA
|
26,8
x
|
-33,1
x
|
15,9
x
|
20,9
x
|
-62,4
x
|
-7,35
x
|
Bedrijfswaarde/FCF
|
34,8
x
|
-258
x
|
-13,5
x
|
11,1
x
|
1,54
x
|
-1,1
x
|
FCF Yield
|
2,88%
|
-0,39%
|
-7,4%
|
9,03%
|
64,9%
|
-91,1%
|
Price to Book
|
5,3
x
|
3,56
x
|
3,78
x
|
-4,38
x
|
1,1
x
|
0,81
x
|
Aantal aandelen (in duizenden)
|
61.251
|
61.251
|
61.251
|
61.251
|
61.251
|
61.251
|
Referentieprijs
2 |
267,2
|
198,0
|
109,2
|
178,9
|
148,2
|
108,4
|
Datum van publicatie
|
14/08/18
|
6/09/19
|
2/12/20
|
3/09/21
|
6/09/22
|
7/09/23
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
5.928
|
4.567
|
5.441
|
6.248
|
6.612
|
4.599
|
EBITDA
1 |
953
|
-558,1
|
861,2
|
872,6
|
-62,91
|
-641,2
|
Bedrijfsresultaat (EBIT)
1 |
387,1
|
-1.098
|
429
|
427,3
|
-489,6
|
-1.027
|
Operationele Marge
|
6,53%
|
-24,04%
|
7,88%
|
6,84%
|
-7,41%
|
-22,34%
|
Resultaat voor belastingen (EBT)
1 |
-661,4
|
486,2
|
-1.712
|
-1.442
|
14.488
|
128
|
Nettowinst (verlies)
1 |
-739,8
|
377,3
|
-1.943
|
-1.477
|
10.779
|
-332,4
|
Nettomarge
|
-12,48%
|
8,26%
|
-35,71%
|
-23,64%
|
163,01%
|
-7,23%
|
WPA
2 |
-12,08
|
6,159
|
-31,72
|
-24,11
|
176,0
|
-5,426
|
Free Cash Flow
1 |
735,6
|
-71,6
|
-1.015
|
1.648
|
2.548
|
-4.293
|
FCF-marge
|
12,41%
|
-1,57%
|
-18,65%
|
26,38%
|
38,53%
|
-93,34%
|
Kasstroomconversie (ebitda)
|
77,18%
|
-
|
-
|
188,85%
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
23,63%
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
14/08/18
|
6/09/19
|
2/12/20
|
3/09/21
|
6/09/22
|
7/09/23
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
9.207
|
6.320
|
7.020
|
7.283
|
-
|
-
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
5.151
|
1.928
|
Hefboom (schuld/ebitda)
|
9,661
x
|
-11,33
x
|
8,151
x
|
8,346
x
|
-
|
-
|
Free Cash Flow
1 |
736
|
-71,6
|
-1.015
|
1.648
|
2.548
|
-4.293
|
ROE (netto-inkomsten/eigen vermogen)
|
-22,6%
|
12,5%
|
-69,2%
|
814%
|
351%
|
-3,94%
|
ROA (netto-inkomsten/totale activa)
|
1,42%
|
-4,6%
|
1,94%
|
2,08%
|
-2,07%
|
-4,24%
|
Totale activa
1 |
-52.105
|
-8.199
|
-100.205
|
-71.038
|
-521.297
|
7.842
|
Nettoactief per aandeel
2 |
50,40
|
55,60
|
28,90
|
-40,90
|
135,0
|
134,0
|
Cashflow per aandeel
2 |
2,680
|
2,360
|
6,570
|
8,500
|
8,220
|
6,510
|
Capex
1 |
152
|
47,8
|
69,1
|
218
|
125
|
409
|
Capex/omzet
|
2,57%
|
1,05%
|
1,27%
|
3,48%
|
1,89%
|
8,9%
|
Datum van publicatie
|
14/08/18
|
6/09/19
|
2/12/20
|
3/09/21
|
6/09/22
|
7/09/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +19,98% | 43,67 mld. | | +20,67% | 22,51 mld. | | +14,38% | 14,6 mld. | | +14,32% | 13,74 mld. | | +44,72% | 11,91 mld. | | -8,37% | 7,04 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +11,39% | 5,42 mld. |
Generieke geneesmiddelen
|